Page 1

INTERIM REPORT MED STIM Q1 2021 Sales for the quarter ended at MNOK 102.6 ( MNOK 103.1 ) , on par with the sales record set in Q1 last year . Currency neutral , sales increased by 1.5 % . Second best quarter ever for operating result ( EBIT ) at MNOK 29.0 ( MNOK 24.8 ) , an increase of 17.3 % over last year . EBIT margin was 28.3 % . Medistim partners with Liva Nova as distributor for India . The General Assembly decided to pay a dividend of NOK 3.00 per share . www.medistim.com